» Articles » PMID: 8630025

Stimulation by C-type Natriuretic Peptide of the Differentiation of Clonal Osteoblastic MC3T3-E1 Cells

Overview
Publisher Elsevier
Specialty Biochemistry
Date 1996 Apr 25
PMID 8630025
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

We examined the effects of C-type natriuretic peptide (CNP) and B-type natriuretic peptide receptor (NPR-B) system, which stimulates the intracellular production of cGMP, on osteoblastic differentiation using clonal murine calvarial MC3T3-E1 cells. CNP-like immunoreactivity was detected in the conditioned medium and in lysates of MC3T3-E1 cells. Exposure of cells to CNP caused an increase in the intracellular production of cGMP and the increase was dose-dependent, while ANP had no effect. These results imply that CNP regulates osteoblastic metabolism via NPR-B in an autocrine manner. Northern blot analysis revealed that treatment of MC3T3-E1 cells with CNP increased the steady-state levels of mRNAs for type-I collagen, cellular alkaline phosphatase (ALPase), and osteocalcin, which are well known as markers of osteoblastic differentiation. Our observations suggest the possibility that CNP functions as a local regulator of osteoblastic differentiation, acting via a cGMP-mediated pathway.

Citing Articles

Midregional Proatrial Natriuretic Peptide (MRproANP) is associated with vertebral fractures and low bone density in patients with chronic obstructive pulmonary disease (COPD).

Trudzinski F, Jorres R, Alter P, Watz H, Vogelmeier C, Kauczor H Respir Res. 2024; 25(1):274.

PMID: 39003487 PMC: 11245771. DOI: 10.1186/s12931-024-02902-2.


Resveratrol-Induced Suppression of C-type Natriuretic Peptide Associates With Increased Vertebral Bone Density in Postmenopausal Women.

Prickett T, Howe P, Espiner E JBMR Plus. 2023; 7(5):e10732.

PMID: 37197320 PMC: 10184013. DOI: 10.1002/jbm4.10732.


Urinary C-type natriuretic peptide: an emerging biomarker for heart failure and renal remodeling.

Zakeri R, Burnett Jr J, Sangaralingham S Clin Chim Acta. 2014; 443:108-13.

PMID: 25512164 PMC: 4409864. DOI: 10.1016/j.cca.2014.12.009.


C-type natriuretic peptide inhibiting vascular calcification might involve decreasing bone morphogenic protein 2 and osteopontin levels.

Chen J, Zhang J, Cai Y, Zhou Y, Wen G, Tang C Mol Cell Biochem. 2014; 392(1-2):65-76.

PMID: 24710639 DOI: 10.1007/s11010-014-2019-1.


E2a-Pbx1 induces aberrant expression of tissue-specific and developmentally regulated genes when expressed in NIH 3T3 fibroblasts.

Fu X, Kamps M Mol Cell Biol. 1997; 17(3):1503-12.

PMID: 9032278 PMC: 231876. DOI: 10.1128/MCB.17.3.1503.